Local and Intraperitoneal Analgetics in Gynecologic Laparoscopy for Post Operative Pain Relief

Browse trials for

• Pain, Postoperative 5,093
• Postoperative Complications 1,233

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's planned enrollment of 120 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Lead sponsor

Wolfson Medical Center is the lead sponsor of 113 studies on the registry; 16 are open to participants now.

Study arms

• Experimental
  Sub cutaneous+Intraperitoneal

  Sub cutaneous Bupivacaine+ Intraperitoneal bupivacaine

  Drug: Bupivacaine

• Active comparator
  Sub cutaneous+Placebo

  Sub cutaneous Bupivacaine+ Intraperitoneal Nacl 0.9%

  Drug: Bupivacaine

• Active comparator
  Placebo+Intraperitoneal

  Sub cutaneous Nacl 0.9%+ Intraperitoneal bupivacaine

  Drug: Bupivacaine

• Placebo comparator
  Placebo+Placebo

  Sub cutaneous Nacl 0.9%+ Intraperitoneal Nacl 0.9%

  Drug: Bupivacaine

Interventions

• DrugBupivacaine

  Sub cutaneous and/or Intraperitoneal Marcaine application

  Also known as: Marcaine

Primary outcomes

1. Pain level during movement, 8 hours after laparoscopy

   Time frame: 8 hours

Publications

• Gluck O, Barber E, Feldstein O, Tal O, Kerner R, Keidar R, Wolfson I, Ginath S, Bar J, Sagiv R. The effect of subcutaneous and intraperitoneal anesthesia on post laparoscopic pain: a randomized controlled trial. Sci Rep. 2021 Jan 8;11(1):81. doi: 10.1038/s41598-020-80130-6. PubMed 33420214 ↗

Individual participant data

Plan to share: No